4D pharma plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
4D pharma plc reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value of $0.58 per share for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-31.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue · last filed 2022-03-31
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2021-12-31 | $0.58 20-F · filed 2022-03-31 |
| 2020-12-31 | $1.49 20-F · filed 2022-03-31 |
| 2019-12-31 | $11.18 20-F/A · filed 2021-04-30 |